Newsroom

ATLANTA--(BUSINESS WIRE)--Pinnacle Financial Partners, Inc. (NYSE: PNFP) today reported financial results for the quarter ended June 30, 2026....

TORONTO--(BUSINESS WIRE)--Fiducie de placement immobilier Propriétés de Choix (« Propriétés de Choix » ou la « Fiducie ») (TSX : CHP.UN) a annoncé aujourd’hui ses résultats financiers consolidés pour le trimestre et le semestre clos le 30 juin 2026. Le rapport du deuxième trimestre aux porteurs de parts peut être consulté sous l’onglet « Investisseurs » du site Web de la Fiducie, à l’adresse www.choicereit.ca/fr, ainsi que sur SEDAR+, à l’adresse www.sedarplus.ca. « Nous sommes ravis des résult...

TORONTO--(BUSINESS WIRE)--Choice Properties Real Estate Investment Trust (“Choice Properties” or the “Trust”) (TSX: CHP.UN) today announced its consolidated financial results for the three and six months ended June 30, 2026. The Second Quarter Report to Unitholders is available in the Investors section of the Trust’s website at www.choicereit.ca, and has been filed on SEDAR+ at www.sedarplus.ca. “We are pleased with Choice Properties’ second quarter results, highlighted by robust leasing spread...

SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems, Inc., “iVeena” a clinical-stage ophthalmic pharmaceutical company developing innovative therapies for eye diseases, today announced a successful End-of-Phase 1 Type B meeting with the U.S. Food and Drug Administration (FDA) for IVMED-85, an investigational, non-atropine eye drop being developed for the treatment of pediatric myopia. The meeting followed the recently announced successful completion of iVeena's Phase 1 clinical study evalu...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced a clinical supply agreement with AVEO Oncology, an LG Chem company (“AVEO”). Under the agreement, the companies will evaluate casdatifan, Arcus’s investigational small-molecule HIF-2α inhibitor, in combination with tivozan...

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek Logistics Partners, LP (NYSE: DKL) (“Delek Logistics”) today declared its quarterly cash distribution for the second quarter 2026 of $1.135 per common limited partner unit, or $4.54 per common limited partner unit on an annualized basis. The second quarter 2026 cash distribution is payable on August 10, 2026, to unitholders of record on August 3, 2026. About Delek Logistics Partners, LP Delek Logistics is a midstream energy master limited partnership hea...

NEW YORK--(BUSINESS WIRE)--BlackRock Science and Technology Trust (NYSE: BST) and BlackRock Science and Technology Term Trust (NYSE: BSTZ) (each, a "Fund" and together, the "Funds") announced today the declaration of special distributions, payable on September 30, 2026 to shareholders of record as of September 15, 2026 (ex-date September 15, 2026). The special distributions reflect substantial realized gains generated by the Funds' strong investment performance, including cumulative fiscal year...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Primoris Services Corporation (“Primoris” or the “Company”) (NYSE: PRIM) common stock between August 5, 2025 and June 22, 2026, inclusive (the “Class Period”). Primoris investors have until September 21, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PRIMORIS SERVICES CORPORATION (PRIM), CONTACT THE LAW OFFICE...

BLOOMINGTON, Minn.--(BUSINESS WIRE)--The Toro Company Elects President and Chief Operating Officer Edric C. Funk to Succeed Richard M. Olson as Chief Executive Officer...

LANSING, Mich.--(BUSINESS WIRE)--Jackson Financial Inc.1 (NYSE: JXN) (Jackson®) today announced Laura Prieskorn, President and Chief Executive Officer, has shared her plans to retire at the end of 2026. Don Cummings, Executive Vice President and Chief Financial Officer, will succeed Prieskorn as President and CEO and as a member of the JFI Board of Directors, effective October 1, 2026. Brian Walta will succeed Cummings as Executive Vice President and Chief Financial Officer, also effective Octo...